Shenzhen YHLO Biotech Co., Ltd.

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
23.98 ^CNY	+0.13%		+6.63%	+4.85%

Apr. 19	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 23	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shenzhen YHLO Biotech Co., Ltd.(XSSC:688575) added to S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
YHLO Biotech Secures US FDA Clearance for Two In-Vitro Diagnostics Products	Dec. 13	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shenzhen YHLO Biotech Co., Ltd.(XSSC:688575) added to S&P Global BMI Index	23-09-18	CI
YHLO Biotech Registers Reagent For Detecting Heart Failure	23-09-14	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2023.	23-05-16	CI
YHLO Biotech Unit Gets Certification for Two Medical Devices	23-05-10	MT
YHLO Biotech Unit Registers New Medical Device	23-05-04	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
YHLO Biotech Gets Registration Certificate for Automatic Biochemical Analyzer	23-04-05	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
YHLO Biotech Gets Registration Certificate for Anti-Desmoglein 3 Antibody Detection Kit	23-02-03	MT
YHLO Biotech's COVID-19 Antigen Kit Added to WHO's Emergency Use List	22-11-04	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Longlight announced that it has received $1.380000 million in funding from Shenzhen YHLO Biotech Co., Ltd., Yanghe Capital Holding Group Limited and other investors.	22-10-24	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-20	CI
Shenzhen YHLO Biotech Co., Ltd.(SHSE:688575) added to Shanghai Stock Exchange A Share Index	22-05-17	CI
Shenzhen YHLO Biotech Co., Ltd.(SHSE:688575) added to Shanghai Stock Exchange Composite Index	22-05-17	CI
Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2022.	22-05-16	CI
Yunkang Braves Market Turbulence with Launch of $139 Million Hong Kong IPO	22-05-04	MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-18	CI
YHLO Biotech Bags Nearly $53 Million Supply Deal With Japan’s JSR; Shares Fall 3%	22-02-14	MT

Chart Shenzhen YHLO Biotech Co., Ltd.

Duration

Period

More charts

Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Shenzhen YHLO Biotech Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

23.98 CNY

Average target price

28.67 CNY

Spread / Average Target

+19.55%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
SHENZHEN YHLO BIOTECH CO., LTD.	+4.85%	1.88B
SHOCKWAVE MEDICAL, INC.	+73.24%	12.36B
PENUMBRA, INC.	-20.67%	7.83B
MASIMO CORPORATION	+16.18%	7.21B
GETINGE AB	+4.77%	5.97B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+11.77%	5.14B
APT MEDICAL INC.	+29.65%	4.43B
ASAHI INTECC CO., LTD.	-18.81%	3.9B
INARI MEDICAL, INC.	-41.62%	2.2B
SKAN GROUP AG	+1.24%	2.02B

Medical Equipment